Fan Z - Search Results

1

Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion.

Chaganty BKR, Qiu S, Gest A, Lu Y, Ivan C, Calin GA, Weiner LM, Fan Z. Chaganty BKR, et al. Among authors: fan z. Cancer Lett. 2018 Aug 28;430:47-56. doi: 10.1016/j.canlet.2018.05.009. Epub 2018 May 8. Cancer Lett. 2018. PMID: 29746929 Free PMC article.

2

Constitutively active Harvey Ras confers resistance to epidermal growth factor receptor-targeted therapy with cetuximab and gefitinib.

Luwor RB, Lu Y, Li X, Liang K, Fan Z. Luwor RB, et al. Among authors: fan z. Cancer Lett. 2011 Jul 1;306(1):85-91. doi: 10.1016/j.canlet.2011.02.035. Epub 2011 Mar 15. Cancer Lett. 2011. PMID: 21411223 Free PMC article.

3

The anti-EGFR antibody cetuximab sensitizes human head and neck squamous cell carcinoma cells to radiation in part through inhibiting radiation-induced upregulation of HIF-1α.

Lu H, Liang K, Lu Y, Fan Z. Lu H, et al. Among authors: fan z. Cancer Lett. 2012 Sep 1;322(1):78-85. doi: 10.1016/j.canlet.2012.02.012. Epub 2012 Feb 17. Cancer Lett. 2012. PMID: 22348829 Free PMC article.

4

Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition.

Ai M, Liang K, Lu Y, Qiu S, Fan Z. Ai M, et al. Among authors: fan z. Cancer Biol Ther. 2013 Mar;14(3):237-45. doi: 10.4161/cbt.23295. Epub 2013 Jan 4. Cancer Biol Ther. 2013. PMID: 23291984 Free PMC article.

5

A novel role of EMMPRIN/CD147 in transformation of quiescent fibroblasts to cancer-associated fibroblasts by breast cancer cells.

Xu J, Lu Y, Qiu S, Chen ZN, Fan Z. Xu J, et al. Among authors: fan z. Cancer Lett. 2013 Jul 28;335(2):380-6. doi: 10.1016/j.canlet.2013.02.054. Epub 2013 Mar 6. Cancer Lett. 2013. PMID: 23474495 Free PMC article.

6

Autocrine/paracrine erythropoietin regulates migration and invasion potential and the stemness of human breast cancer cells.

Liang K, Qiu S, Lu Y, Fan Z. Liang K, et al. Among authors: fan z. Cancer Biol Ther. 2014 Jan;15(1):89-98. doi: 10.4161/cbt.26717. Epub 2013 Oct 22. Cancer Biol Ther. 2014. PMID: 24100272 Free PMC article.

7

Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.

Ai Z, Lu Y, Qiu S, Fan Z. Ai Z, et al. Among authors: fan z. Cancer Lett. 2016 Apr 1;373(1):36-44. doi: 10.1016/j.canlet.2016.01.009. Epub 2016 Jan 19. Cancer Lett. 2016. PMID: 26801746 Free PMC article.

8

Identification and validation of COX-2 as a co-target for overcoming cetuximab resistance in colorectal cancer cells.

Lu Y, Shi C, Qiu S, Fan Z. Lu Y, et al. Among authors: fan z. Oncotarget. 2016 Oct 4;7(40):64766-64777. doi: 10.18632/oncotarget.8649. Oncotarget. 2016. PMID: 27074568 Free PMC article.

9

Trastuzumab upregulates expression of HLA-ABC and T cell costimulatory molecules through engagement of natural killer cells and stimulation of IFNγ secretion.

Chaganty BK, Lu Y, Qiu S, Somanchi SS, Lee DA, Fan Z. Chaganty BK, et al. Among authors: fan z. Oncoimmunology. 2015 Oct 29;5(4):e1100790. doi: 10.1080/2162402X.2015.1100790. eCollection 2016 Apr. Oncoimmunology. 2015. PMID: 27141382 Free PMC article.

10

ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis.

Lu H, Li X, Lu Y, Qiu S, Fan Z. Lu H, et al. Among authors: fan z. Cancer Lett. 2016 Oct 10;381(1):23-30. doi: 10.1016/j.canlet.2016.07.020. Epub 2016 Jul 19. Cancer Lett. 2016. PMID: 27450723 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,397 results

Search Page

Filters